Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study.
| Image |  |
|---|---|
| Description | scientific article published on 19 July 2016 |
| Author/s |
author: Christelle Levy Laurence Vanlemmens |
| Publication date | July 19, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |